The explosion of the new coronavirus (SARS-CoV-2) pandemic has brought the role of the
angiotensin converting enzyme 2 (ACE2) back into the scientific limelight. Since SARS-CoV …

Currently, the world is in the seventh month of the COVID-19 pandemic. Globally, infections
with novel SARS-CoV-2 virus are continuously rising with mounting numbers of deaths …

The development of COVID-19 vaccines is occurring at a rapid pace, with the potential for a
vaccine to be available within 6 months. So who should be prioritized for vaccination when …

Objective To investigate the clinical course and impact of coronavirus disease 2019 (COVID‐
19) infection on pregnant women. Methods A prospective cohort study was conducted on …

Immunological adaptations in pregnancy allow maternal tolerance of the semi-allogeneic
fetus but also increase maternal susceptibility to infection. At implantation, the endometrial …

Fetal risks for women exposed to SARS-CoV-2 and subsequent pregnancy outcomes
remain uncertain [1]. Recent reports have raised controversial concerns regarding the …

The new coronavirus (SARS-Cov-2) was first identified in late 2019 as the new RNA virus in
the coronaviridae family responsible for causing COVID-19 in the residents of China's Hubei …

Abstract Coronavirus disease 2019 (COVID-19) pandemic has spread rapidly across the
world. The vast majority of patients with COVID-19 manifest mild to moderate symptoms but …

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has alarmed the world since its first emergence. As pregnancy …

The aim of this study is to share the comprehensive experience of a tertiary pandemic center
on pregnant women with COVID‐19 and to compare clinical outcomes between pregnancy …